Skip to main content

Fiscal Wizard · Single-issue tearsheet

MDXG / Jun 22, 2026 Run #7658

MDXG

MiMedx Group, Inc.

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. The company's wound care products include EPIFIX, EPICORD, EPIXPRESS, CHORIOFIX, EMERGE, CELERA, REGENKIT WOUND GEL, and EPIEFFECT sheets for use as protective barriers that enables a healthcare provider to select an appropriate size graft based on the size of the wound to reduce product waste. Its surgical and other product offerings consist of AMNIOFIX, AMNIOBURN, AMNIOCORD, AXIOFILL, HELIOGEN, and AMNIOEFFECT for applications in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery, and various orthopedic repairs and reconstructions. The company's products are used in the areas of wound care, burn, and surgical fields in healthcare. It sells its products through direct sales force and independent sales agents, as well as to individual customers and independent distributors in the United States. The company has a strategic alliance with Vaporox, Inc. for the promotion of their wound care offerings. The company was founded in 2006 and is headquartered in Marietta, Georgia.

Composite verdict

D 42.8 / 100
Bearish setup · Reversal 9 drivers · 2 gates blocking
  • Accumulation/Distribution Line
  • Engulfing
  • Multi Top/Bottom
Consider long put target Δ ~0.70 · ~35 DTE Bearish setup, Grade A → ITM put target

Industry rank 100th of 598 in Biotechnology

rescore-sweep
Technical synthesisRegime: range
Bull 0%Evidence: High · 24 signals100% Bear
Momentum Bearish 35Mean-reversion Bearish 36

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes fromMargin of safety -56%
Asset value $1.72Earnings power value $4.49Price $3.67

The discount is mostly unpriced earnings power: price ($3.67) sits between asset value ($1.72) and no-growth earnings power value ($4.49).

Fundamentals Strong

80.9 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Asset Turnover 100
Margin of Safety 0
Free Cash Flow Yield 100
OCF to Net Income 0
Return on Assets 87
Inventory Turnover 0

Technicals Bearish

4.7 / 100

Bearish setup leads (Accumulation/Distribution Line, Engulfing, Multi Top/Bottom); bulls gated by guards. · 43 signals shown.

Strongest
Weakest
Accumulation/Distribution Line 6
Engulfing 11
Parabolic SAR Flip 19

Risk Gates

2 blocking 7 caution

2 guards active, 17 signals gated.

ADX Trend Weakness Blocking

Weak trend strength blocks trend-following signals in either direction.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Cash Ratio Caution

Visual cash-cushion flag — does not mute signals.

Current Ratio Caution

Visual liquidity flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for MDXG.